Discovery of an allosteric 14-3-3 inhibitor for suppressing NRF2-driven cancer via phenotypic screening and chemoproteomic-based target deconvolution

Journal:
Chemical Science
Published:
DOI:
10.1039/d5sc04324g
Affiliations:
3
Authors:
10
Go to article
Institutions Authors Share
China Pharmaceutical University (CPU), China
8.000000
 0.80
State Key Laboratory of Natural Medicines (SKLNM), CPU, China
1.000000
 0.10
Suzhou Medical College, Soochow University, China
1.000000
 0.10
Interested in Oncology and Carcinogenesis?